Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf.
Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Augustenburger Platz 1, Berlin.
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e1008-e1012. doi: 10.1097/MEG.0000000000002136.
Nonalcoholic fatty liver disease (NAFLD) has emerged as the most prevalent chronic liver disease, with about one in four people being affected in most areas of the world. Due to its strong association with metabolic syndrome, NAFLD is associated with high morbidity and mortality. Recent data have suggested a pathophysiological association between NAFLD and thyroid disease, but most studies are explorative and results remained conflicting. Here, we aimed at evaluating a potential association between NAFLD and hypothyroidism as well as autoimmune thyroiditis primary care patients in Germany.
Incidence rates of hypothyroidism and autoimmune thyroiditis were compared between a cohort of n = 40,583 patients with NAFLD and a cohort of equal size without NAFLD that was matched by sex, age, index year, obesity and diabetes within 10 years from the index date.
Within the 10 years observation period, incidence of hypothyroidism was significantly higher among patients with NAFLD compared to patients without NAFLD [hazard ratio: 1.53 (95% confidence interval, 1.43-1.64), P < 0.001]. Importantly, regression analysis revealed that the association was significant in both men and women patients as well as in patients from all age groups. Moreover, NAFLD patients showed a significantly higher incidence rate of autoimmune thyroiditis compared to patients without NAFLD [hazard ratio: 1.55 (95% confidence interval, 1.34-1.79), P < 0.001]. This association was most pronounced in patients >70 years.
Our study provides strong evidence for a significant association between NAFLD and hypothyroidism as well as autoimmune thyroiditis in a large population-based cohort in Germany. This finding should trigger a particular awareness of thyroid diseases in this increasingly important patient group.
非酒精性脂肪性肝病(NAFLD)已成为最常见的慢性肝病,在世界上大多数地区,约有四分之一的人受到影响。由于其与代谢综合征密切相关,NAFLD 与高发病率和死亡率相关。最近的数据表明,NAFLD 与甲状腺疾病之间存在病理生理关联,但大多数研究都是探索性的,结果仍存在争议。在这里,我们旨在评估德国非酒精性脂肪性肝病患者与甲状腺功能减退症和自身免疫性甲状腺炎之间的潜在关联。
比较了 40583 名 NAFLD 患者队列和一个大小相等的无 NAFLD 患者队列的甲状腺功能减退症和自身免疫性甲状腺炎的发病率,这些患者是通过性别、年龄、索引年、肥胖和 10 年内糖尿病与索引日期相匹配的。
在 10 年的观察期内,与无 NAFLD 的患者相比,NAFLD 患者的甲状腺功能减退症发病率显著更高[风险比:1.53(95%置信区间,1.43-1.64),P<0.001]。重要的是,回归分析显示,这种关联在男性和女性患者以及所有年龄组的患者中均有意义。此外,与无 NAFLD 的患者相比,NAFLD 患者的自身免疫性甲状腺炎发病率显著更高[风险比:1.55(95%置信区间,1.34-1.79),P<0.001]。这种关联在>70 岁的患者中最为明显。
我们的研究为德国大型基于人群的队列中 NAFLD 与甲状腺功能减退症以及自身免疫性甲状腺炎之间的显著关联提供了有力证据。这一发现应该在这个日益重要的患者群体中引起对甲状腺疾病的特别关注。